Lycopene‐whey complex (bioavailable lycopene) and risk of atherosclerotic plaques Scientific substantiation of a health claim related to Lycopene‐whey complex (bioavailable lycopene) and reduction of the risk of atherosclerotic plaques pursuant to Article 14 of Regulation (EC) No 1924/2006

Lycopene‐whey complex (bioavailable lycopene) and risk of atherosclerotic plaques Scientific substantiation of a health claim related to Lycopene‐whey complex (bioavailable lycopene) and reduction of the risk of atherosclerotic plaques pursuant to Article 14 of Regulation (EC) No 1924/2006

Bibliographic Details
Main Author: European Food Safety Authority (EFSA)
Format: Article
Language:English
Published: Wiley 2009-08-01
Series:EFSA Journal
Subjects:
lycopene
lipoprotein oxidisability
atherosclerotic plaques
atherosclerosis
health claim
Online Access:https://doi.org/10.2903/j.efsa.2009.1179

Internet

https://doi.org/10.2903/j.efsa.2009.1179

Similar Items